Role of Blood Cell Indexes in Progresses to ESRD

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl. 2022;12(1):7–11.

Article  Google Scholar 

Collaborators GA. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022;376.

Basto-Abreu A, Barrientos-Gutierrez T, Wade AN, Oliveira de Melo D, Semeão de Souza AS, Nunes BP, Perianayagam A, Tian M, Yan LL, Ghosh A, Miranda JJ. Multimorbidity matters in low and middle-income countries. J Multimorb Comorb. 2022; 12:26335565221106074. https://doi.org/10.1177/26335565221106074. PMID: 35734547; PMCID: PMC9208045.

Lv J-C, Zhang L-X. Prevalence and disease burden of chronic kidney disease. Renal Fibrosis Mech Therapies. 2019:3–15.

Silverstein DM. Inflammation in chronic kidney disease: role in the progression of renal and cardiovascular disease. Pediatr Nephrol. 2009;24:1445–52.

Article  PubMed  Google Scholar 

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao MH, Lv J, Garg AX, Knight J, Rodgers A, Gallagher M, Kotwal S, Cass A, Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82. https://doi.org/10.1016/S0140-6736(14)61601-9. (Epub 2015 Mar 13 PMID: 25777665).

Article  PubMed  Google Scholar 

Landray MJ, Wheeler DC, Lip GY, Newman DJ, Blann AD, McGlynn FJ, Ball S, Townend JN, Baigent C. Inflammation, endothelial dysfunction, and platelet activation in patients with chronic kidney disease: the chronic renal impairment in Birmingham (CRIB) study. Am J Kidney Dis. 2004;43(2):244–53.

Article  CAS  PubMed  Google Scholar 

Akchurin OM, Kaskel F. Update on inflammation in chronic kidney disease. Blood Purif. 2015;39(1–3):84–92.

Article  CAS  PubMed  Google Scholar 

Coradduzza D, Solinas T, Balzano F, Culeddu N, Rossi N, Cruciani S, Azara E, Maioli M, Zinellu A, De Miglio MR, Madonia M, Falchi M, Carru C. miRNAs as molecular biomarkers for prostate cancer. J Mol Diagn. 2022;24(11):1171–80. https://doi.org/10.1016/j.jmoldx.2022.05.005. (Epub 2022 Jul 11 PMID: 35835374).

Article  CAS  PubMed  Google Scholar 

Coradduzza D, Ghironi A, Azara E, Culeddu N, Cruciani S, Zinellu A, Maioli M, De Miglio MR, Medici S, Fozza C, Carru C. Role of polyamines as biomarkers in lymphoma patients: a pilot study. Diagnostics (Basel). 2022;12(9):2151. https://doi.org/10.3390/diagnostics12092151. PMID: 36140552; PMCID: PMC9497571.

Coradduzza D, Arru C, Culeddu N, Congiargiu A, Azara EG, Scanu AM, Zinellu A, Muroni MR, Rallo V, Medici S, Carru C, Angius A, De Miglio MR. Quantitative metabolomics to explore the role of plasma polyamines in colorectal cancer. Int J Mol Sci. 2022;24(1):101. https://doi.org/10.3390/ijms24010101.PMID:36613539;PMCID:PMC9820724.

Article  PubMed  PubMed Central  Google Scholar 

Coradduzza D, Solinas T, Azara E, Culeddu N, Cruciani S, Zinellu A, Medici S, Maioli M, Madonia M, Carru C. Plasma polyamine biomarker panels: agmatine in support of prostate cancer diagnosis. Biomolecules. 2022;12(4):514. https://doi.org/10.3390/biom12040514.PMID:35454104;PMCID:PMC9024899.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Coradduzza D, Azara E, Medici S, Arru C, Solinas T, Madonia M, Zinellu A, Carru C. A preliminary study procedure for detection of polyamines in plasma samples as a potential diagnostic tool in prostate cancer. J Chromatogr B Analyt Technol Biomed Life Sci. 2021;1162: 122468. https://doi.org/10.1016/j.jchromb.2020.122468. (Epub 2020 Nov 30 PMID: 33370684).

Article  CAS  PubMed  Google Scholar 

Ergin G, Değer SM, Köprü B, Derici Ü, ARINSOY ST. High neutrophil-to- lymphocyte ratio predicts acute allograft rejection in kidney transplantation: a retrospective study. Turkish J Med Sci. 2019;49(2):525–30.

Gameiro J, Fonseca JA, Dias JM, Milho J, Rosa R, Jorge S, Lopes JA. Neutrophil, lymphocyte and platelet ratio as a predictor of postoperative acute kidney injury in major abdominal surgery. BMC Nephrol. 2018;19(1):320. https://doi.org/10.1186/s12882-018-1073-4.PMID:30419844;PMCID:PMC6231266.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kolonko A, Dwulit T, Skrzypek M, Więcek A. Potential utility of neutrophil-to- lymphocyte, platelet-to-lymphocyte, and neutrophil, lymphocyte, and platelet ratios in differential diagnosis of kidney transplant acute rejection: a retrospective, propensity score matched analysis. Ann Transplant. 2022;27:e937239–41.

Article  PubMed  PubMed Central  Google Scholar 

Catabay C, Obi Y, Streja E, Soohoo M, Park C, Rhee CM, Kovesdy CP, Hamano T, Kalantar-Zadeh K. Lymphocyte cell ratios and mortality among incident hemodialysis patients. Am J Nephrol. 2017;46(5):408–416. https://doi.org/10.1159/000484177. Epub 2017 Nov 7. PMID: 29130984; PMCID: PMC5777311.

Yilmaz G, Sevinc C, Ustundag S, Yavuz YC, Hacıbekiroglu T, Hatipoglu E, Baysal M. The relationship between mean platelet volume and neutrophil/lymphocyte ratio with inflammation and proteinuria in chronic kidney disease. Saudi J Kidney Dis Transpl. 2017;28(1):90–4.

Article  PubMed  Google Scholar 

Xiang F, Chen R, Cao X, Shen B, Liu Z, Tan X, Ding X, Zou J. Monocyte/lymphocyte ratio as a better predictor of cardiovascular and all-cause mortality in hemodialysis patients: A prospective cohort study. Hemodial Int. 2018;22(1):82–92. https://doi.org/10.1111/hdi.12549. (Epub 2017 Apr 12 PMID: 28403540).

Article  PubMed  Google Scholar 

Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ. Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease. Clin Exp Nephrol. 2013;17(4):532–40. https://doi.org/10.1007/s10157-012-0728-x. (Epub 2012 Nov 20 PMID: 23180042).

Article  PubMed  Google Scholar 

Tonyali S, Ceylan C, Yahsi S, Karakan MS. Does neutrophil to lymphocyte ratio demonstrate deterioration in renal function? Ren Fail. 2018;40(1):209–12.

Article  PubMed  PubMed Central  Google Scholar 

Kocyigit I, Eroglu E, Unal A, Sipahioglu MH, Tokgoz B, Oymak O, Utas C. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease. J Nephrol. 2013;26(2):358–65. https://doi.org/10.5301/jn.5000152. (Epub 2012 May 8 PMID: 22573523).

Article  CAS  PubMed  Google Scholar 

Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform. 2014;48(2):193–204.

Article  PubMed  Google Scholar 

KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Offic J Int Soc Nephrol. 2012; 3(1).

Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130(6):461–70.

Stevens PE, Levin A. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–30.

Article  PubMed  Google Scholar 

Okyay GU, Inal S, Oneç K, Er RE, Paşaoğlu O, Paşaoğlu H, Derici U, Erten Y. Neutrophil to lymphocyte ratio in evaluation of inflammation in patients with chronic kidney disease. Ren Fail. 2013;35(1):29–36. https://doi.org/10.3109/0886022X.2012.734429. (Epub 2012 Nov 1 PMID: 23113674).

Article  CAS  PubMed  Google Scholar 

Yao C, Liu X, Tang Z. Prognostic role of neutrophil-lymphocyte ratio and platelet- lymphocyte ratio for hospital mortality in patients with AECOPD. Int J Chron Obstruct Pulmon Dis. 2017;12:2285–90.

Article  PubMed  PubMed Central  Google Scholar 

Yang Z, Zhang Z, Lin F, Ren Y, Liu D, Zhong R, Liang Y. Comparisons of neutrophil-, monocyte-, eosinophil-, and basophil-lymphocyte ratios among various systemic autoimmune rheumatic diseases. APMIS. 2017;125(10):863–71. https://doi.org/10.1111/apm.12722. (Epub 2017 Aug 2 PMID: 28766758).

Article  CAS  PubMed  Google Scholar 

Krenn-Pilko S, Langsenlehner U, Stojakovic T, Pichler M, Gerger A, Kapp KS, Langsenlehner T. The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients. Tumour Biol. 2016;37(1):361–8. https://doi.org/10.1007/s13277-015-3805-4. (Epub 2015 Jul 29 PMID: 26219894).

Article  PubMed  Google Scholar 

Van Soest RJ, Templeton AJ, Vera-Badillo FE, Mercier F, Sonpavde G, Amir E, Tombal B, Rosenthal M, Eisenberger MA, Tannock IF, de Wit R. Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials. Ann Oncol. 2015;26(4):743–9. https://doi.org/10.1093/annonc/mdu569. (Epub 2014 Dec 15 PMID: 25515657).

Article  PubMed  Google Scholar 

Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013;109(2):395–400. https://doi.org/10.1038/bjc.2013.346. Epub 2013 Jul 2. PMID: 23820252; PMCID: PMC3721404.

Yu Y, Qian L, Cui J. Value of neutrophil-to-lymphocyte ratio for predicting lung cancer prognosis: a meta-analysis of 7,219 patients. Molec Clinic Oncol. 2017;7(3):498–506.

Article  CAS  Google Scholar 

Tatar E, Mirili C, Isikyakar T, Yaprak M, Guvercin G, Ozay E, Asci G. The association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with clinical outcomes in geriatric patients with stage 3–5 chronic kidney disease. Acta Clin Belg. 2016;71(4):221–6. https://doi.org/10.1080/17843286.2016.1159797. (Epub 2016 May 20 PMID: 27309205).

Article  PubMed  Google Scholar 

Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY. Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation. 2002;106(15):1962–7.

Article  CAS  PubMed  Google Scholar 

Turkmen K, Erdur FM, Ozcicek F, Ozcicek A, Akbas EM, Ozbicer A, Demirtas L, Turk S, Tonbul HZ. Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013;17(3):391–6. https://doi.org/10.1111/hdi.12040. (Epub 2013 Mar 24 PMID: 23522328).

Article  PubMed  Google Scholar 

Yaprak M, Turan MN, Dayanan R, Akın S, Değirmen E, Yıldırım M, Turgut F. Platelet-to-lymphocyte ratio predicts mortality better than neutrophil-to-lymphocyte ratio in hemodialysis patients. Int Urol Nephrol. 2016;48(8):1343–8. https://doi.org/10.1007/s11255-016-1301-4. (Epub 2016 Apr 27 PMID: 27118565).

Article  CAS  PubMed  Google Scholar 

Feng JF, Chen S, Yang X. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Medicine. 2017;96(4): e5886.

Article  PubMed  PubMed Central  Google Scholar 

Altunoren O, Akkus G, Sezal DT, Ciftcioglu M, Guzel FB, Isiktas S, Torun GI, Uyan M, Sokmen MF, Sevim HA, Sarısık FN, Senel ME, Erken E, Gungor O. Does neutrophyl to lymphocyte ratio really predict chronic kidney disease progression? Int Urol Nephrol. 2019;51(1):129–37. https://doi.org/10.1007/s11255-018-1994-7. (Epub 2018 Oct 1 PMID: 30276600).

Article  CAS  PubMed  Google Scholar 

Yuan Q, Wang J, Peng Z, Zhou Q, Xiao X, Xie Y, Wang W, Huang L, Tang W, Sun D, Zhang L, Wang F, Zhao MH, Tao L, He K, Xu H; C-STRIDE study

留言 (0)

沒有登入
gif